Credit Suisse’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-328,410
Closed -$6.86M 4244
2022
Q3
$6.86M Buy
328,410
+143,603
+78% +$2.99M 0.01% 1088
2022
Q2
$3.83M Buy
184,807
+77,223
+72% +$1.37M ﹤0.01% 1481
2022
Q1
$1.81M Buy
107,584
+9,171
+9% +$160K ﹤0.01% 2157
2021
Q4
$1.97M Buy
98,413
+6,985
+8% +$132K ﹤0.01% 2800
2021
Q3
$1.66M Sell
91,428
-8,285
-8% -$190K ﹤0.01% 2957
2021
Q2
$2.69M Sell
99,713
-12,947
-11% -$362K ﹤0.01% 2612
2021
Q1
$3.38M Sell
112,660
-8,541
-7% -$291K ﹤0.01% 2414
2020
Q4
$3.48M Buy
121,201
+35,991
+42% +$971K ﹤0.01% 2388
2020
Q3
$2.08M Buy
85,210
+2,582
+3% +$55.7K ﹤0.01% 2395
2020
Q2
$1.48M Buy
82,628
+13,580
+20% +$178K ﹤0.01% 2622
2020
Q1
$562K Sell
69,048
-110,590
-62% -$1.26M ﹤0.01% 3042
2019
Q4
$2.37M Buy
179,638
+115,836
+182% +$1.4M ﹤0.01% 2464
2019
Q3
$759K Sell
63,802
-134
-0.2% -$2.48K ﹤0.01% 3201
2019
Q2
$1.56M Sell
63,936
-19,548
-23% -$563K ﹤0.01% 2628
2019
Q1
$2.66M Buy
+83,484
New +$2.96M ﹤0.01% 2158

Other funds holding CVET

Credit Suisse's CVET Position: Q4 2022 in Review

Credit Suisse sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 328,410 shares — an estimated $6.86M sold.

Credit Suisse first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $6.86M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Credit Suisse reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Credit Suisse sold 328,410 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $6.86M.
  • Credit Suisse first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Credit Suisse's Covetrus, Inc. Common Stock position peaked at $6.86M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.